AOP 3.13% 33.0¢ apollo consolidated limited

demise

  1. 89 Posts.
    lightbulb Created with Sketch. 12
    Is this the end of Apollo?
    if they could only finance the clinical trials of oral insulin and show the market it works it would be on a winner.
    I wonder if a pharmaceutical company will buy the
    interlectual property once they see the huge potential
    of an oral insulin.
 
watchlist Created with Sketch. Add AOP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.